Table 3.
Resistance pattern of S. aureus, E. coli and P. aeruginosa in LF patients
| Isolates (n) | Resistance frequency of bacteria to antibiotics n (%) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gram-positive | TET | CIP | CN | SXT | CC | FOX | C | E | P | ||
| S. aureus (26) | 15(57.69) | 3(11.54) | 3(11.54) | 4(15.38) | 5(19.23) | 5(19.23) | 20(76.92) | 2(7.69) | 23(88.46) | ||
| Gram-negative | TET | CIP | CN | SXT | C | MEM | AM | SAM | CAZ | CRO | CXM |
| E. coli (5) | 5(100.00) | 3(60.00) | 2(40.00) | 5(100.00) | 2(40.00) | 0(0.00) | 5(100.00) | 5(100.00) | 3(60.00) | 3(60.00) | 3(60.00) |
| P. aeruginosa (8) | ND | 2(25.00) | 2(25.00) | ND | ND | 3(37.50) | ND | ND | 2(25.00) | ND | ND |
Key: ND Not determined as there are no breakpoints in EUCAST/CLSI protocols, SXT Sulfamethoxazole-trimethoprim, TET Tetracycline, P Penicillin, CN Gentamicin, SAM Ampicillin-sulbactam, CRO Ceftriaxone, FOX Cefoxitin, CXM Cefuroxime, C Chloramphenicol, CIP Ciprofloxacin, CC Clindamycin, E Erythromycin, MEM Meropenem, AM Ampicillin, CAZ Ceftazidime